Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2026-02-02 @ 6:19 PM
Study NCT ID:
NCT02230761
Status:
COMPLETED
Last Update Posted:
2016-02-08
First Post:
2014-08-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)
Sponsor:
Topokine Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XOPH5-OINT-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None